Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| SANUWAVE Health, Inc.SNVW · Entity 7321 | Exec VP of Sales | January 30, 2026 | February 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
SANUWAVE Health, Inc.
Report date January 30, 2026 · Filed February 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.96 · Expires 2036-01-30 | Direct | 2,500 |
Reported balance
After 2026-01-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-01-30 · Grant · Acquired 2,500 · Balance 2,500 F1: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 30, 2026 Filed Feb 3, 2026 16:04 UTC | SANUWAVE Health, Inc. SNVW · Entity 7321 | GrantStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $26.96 | $0.00 |
DisclosureSEC source: 0002053254-26-000002 · form4-02032026_090206.xml · derivative · entry 1 Wern David Timothy · CIK 0002053254 · Exec VP of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2036-01-30 F1 · derivative.exercise_date: Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. Read SEC document |
| January 08, 2025 Filed Jan 28, 2025 17:14 UTC | SANUWAVE Health, Inc. SNWV · Entity 7321 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $24.81 | $0.00 |
DisclosureSEC source: 0001437749-25-002039 · rdgdoc.xml · derivative · entry 1 Wern David Timothy · CIK 0002053254 · Executive VP of Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-01-08 F1 · derivative.exercise_date: Options will vest over a period of ten years in equal installments on each quarterly anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.